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Neutrophils are the first innate immune cells recruited into sites of infection and 
inflammation, and although they are critical for host defence against microbial pathogens, 
they have also been associated with local tissue damage. Predominant neutrophilic 
inflammation is a key hallmark of many respiratory diseases and the release of proteinases 
and reactive oxygen species (ROS) from primed neutrophils has been implicated in mediating 
the damage to surrounding tissue.[1] Inflammation is further accompanied by severe hypoxia 
(lack of oxygen) within the affected tissue, and is a characteristic of both acute and chronic 
lung diseases, such as acute respiratory distress syndrome (ARDS),[2] chronic obstructive 
pulmonary disease (COPD),[3] and cystic fibrosis (CF) .[4] Considering that tissue hypoxia is 
part of a normal inflammatory response, innate immune cells such as neutrophils and 
macrophages possess important cellular and molecular mechanisms that enable them to 
function effectively at low oxygen concentrations.[5] 
There is considerable interplay between the molecular pathways that regulate hypoxia and 
inflammation. In previous studies, mice exposed to hypoxic conditions (5% O2 for 1 hour) 
demonstrated increased levels of IL-6, TNF and IL-1 in both serum and isolated 
macrophages.[6] In humans, increased levels of IL-6, IL-1RA and C-reactive protein were 
detected in serum after volunteers experienced three overnight stays at altitude.[7] Moreover, 
infiltrating neutrophils directly increase their oxygen consumption in order to assemble the 
NADPH oxidase complex that generates ROS and, in conjunction with superoxide dismutase 
and myeloperoxidase, hydrogen peroxide (H2O2) and hypochlorous acid (HClO), thereby 
depleting local levels of oxygen.[8, 9] Neutrophils are also thought to influence the tissue 
microenvironment during episodes of hypoxia. For example, neutrophil migration across 
epithelia increases the transcriptional activity of hypoxia-inducible genes in epithelial cells, 
which in turn influence the resolution of inflammation.[10] 
Neutrophils have therefore been implicated in the pathogenesis of several inflammatory lung 
diseases associated with tissue hypoxia.[5] However, the mechanisms by which neutrophils 
mediate tissue damage under hypoxic conditions are less clear. Under homeostatic conditions 
neutrophils are short-lived cells that readily undergo apoptosis in order to avoid the release of 
toxic-granule contents. However, under hypoxic conditions neutrophil survival is prolonged, 
which is thought to delay the resolution of inflammation and promote tissue damage, 
potentially through the release of destructive proteinases or ROS.[11] The study by 
Hoenderdos et al. in this issue of Thorax aims to explore the functional link between hypoxia 
and the regulation of neutrophil degranulation in the context airway inflammation. 
Compared to neutrophils incubated under normoxic conditions (atmospheric O2 
concentration), this study demonstrated that neutrophils incubated under hypoxic conditions 
(0.8% O2, 3 kPa for 4 hours) released significantly elevated levels of neutrophil elastase 
(NE), myeloperoxidase (MPO), lactoferrin and metalloproteinase-9 (MMP-9), thereby 
indicating degranulation of azurophil (primary), specific (secondary) and gelatinase (tertiary) 
granules. This effect was largely dependent on priming with granulocyte-macrophage colony 
stimulating factor (GM-CSF) and activation with formylated peptide (fMLP), as little 
degranulation occurred at basal levels in either normoxic or hypoxic conditions. These 
findings support previous studies demonstrating that neutrophils isolated from human 
volunteers, following a period of hypoxemia, released increased levels of NE after fMLP 
stimulation,[12] and neutrophils from healthy volunteers exposed to hypoxia ex vivo (3 kPA 
for 1-4 hours) released NE.[13] However, these two studies reported opposing effects on 
ROS production. 
Previous studies under hypoxia have sometimes given conflicting results, which is likely 
related to differing experimental conditions that affect neutrophil function. There may 
therefore be some merit in standardising methodologies across laboratories, to enable direct 
comparison of studies within the scientific community. It is also important to consider 
whether experimental hypoxic conditions mirror those found in the lung during episodes of 
inflammation. The lung is normally an oxygen-rich organ, with an alveolar PO2 ~110 mm Hg 
compared to other systemic organs (3-20 mm Hg). Therefore, oxygen tensions in a hypoxic 
lung are higher than other organs (~50 mm Hg compared to less than 10 mm Hg).[14] The 
current study exposed neutrophils to hypoxic conditions of 3 kPa, which is equivalent to ~20 
mm Hg, and therefore attempts to recapitulate the physiological conditions within the airway 
epithelium. It is argued that similar mechanistic ex vivo studies should also reflect these 
unique conditions. More challenging will be to recapitulate hypoxic conditions within tissue 
niches or foci of inflammation, such as those that occur in the small airway epithelium in 
COPD and CF. 
The release of neutrophil proteinases has been strongly implicated in promoting tissue 
damage within inflamed lung.[15] In this study, hypoxic supernatants from GM-CSF and 
fMLP stimulated neutrophils increased the detachment and death of epithelial cells compared 
to normoxic neutrophils. Treatment with alpha-1-anti-trypsin further revealed that the toxic 
effects were mediated by proteinases, supporting a role for activated neutrophils in mediating 
tissue damage. The enhanced toxic effects of hypoxic neutrophil supernatants were apparent 
when epithelial cells were cultured in 2D monolayers. However, recapitulating these findings 
in 3D culture systems or, more importantly in vivo, remain a considerable challenge.  
It is important to fully appreciate the significant effect that hypoxia has on downstream 
signalling pathways in both tissue resident cells and infiltrating leukocytes. Eukaryotic cells 
have evolved several oxygen sensing pathways, of which the principal regulators are 
hypoxia-inducible transcription factor-1 and -2 (HIF-1 and HIF-2).[16] Under hypoxic 
conditions HIFs are stabilised, allowing them to translocate to the nucleus and regulate HIF-
response genes.[17] Interestingly, the current study reports that hypoxia-induced 
degranulation of neutrophils is not primarily mediated by HIF-1. Treatment of neutrophils 
with either dimethyloxalyl glycine (DMOG) or desferrioxamine (DFO), which are both HIF-
1 stabilising agents, did not affect NE release. Furthermore, hypoxia did not increase the 
expression of NE but did increase the expression of BNIP-2, both of which are putative HIF-
1 response genes. Taken together these data suggest that NE release following hypoxia-
induced degranulation may be HIF-1 independent, although the contribution of HIF-2 was 
not directly explored in this study. 
Neutrophil degranulation is also thought to be dependent on actin cytoskeletal 
rearrangements. Indeed, hypoxia caused focal actin polymerisation in fMLP stimulated 
neutrophils. However, inhibition of actin polymerisation using cytochalasin B increased NE 
release, while treatment with jasplakinolide (which promotes actin polymerisation) had no 
significant effect on NE release. Actin remodelling is necessary for neutrophil degranulation, 
as well as polarisation and migration in response to exogenous stimuli such as fMLP and IL-
8.[18] Cytoskeletal rearrangements are thought to be a prerequisite for the intracellular 
movement of granules within the cytoplasm, while actin disassembly is necessary for access 
to the inner surface of the plasma membrane. It is therefore plausible that cytochalasin B 
relaxes the actin cytoskeleton and thereby promotes granule fusion with the plasma 
membrane, in a similar way that immune synapses form during polarised secretion of 
cytotoxic T cell granules.[19] 
Degranulation is a tightly regulated process involving the activation of G-protein coupled 
receptors (GPCRs), intracellular calcium mobilisation and ATP-dependent phosphorylation 
of downstream signalling molecules.[18] Treatment with a phospholipase C (PLC) inhibitor 
or EGTA, in order to block intracellular Ca2+, inhibited NE release under hypoxic conditions. 
Furthermore, treatment with thapsigargin, which is a Ca2+ ATPase inhibitor that elevates 
intracellular Ca2+ levels, caused an increase in NE release. These studies therefore confirm 
that Ca2+ mobilisation is an important signalling event during neutrophil degranulation under 
hypoxic conditions. However, the specific downstream targets of Ca2+ during neutrophil 
degranulation remain largely unknown. 
Considering that hypoxia-induced neutrophil degranulation was independent of HIF 
signalling, an alternative PI3K signalling pathway was investigated. A pan PI3K inhibitor 
reduced neutrophil survival under hypoxic conditions, while a pan PI3K inhibitor and a 
PI3Kγ inhibitor completely abolished NE release from GM-CSF and fMLP stimulated 
neutrophils. Inhibition of PI3Kγ also inhibited the downstream phosphorylation of Akt, 
suggesting that the PI3K-Akt pathway may play a role in hypoxia-mediated neutrophil 
degranulation. It will be interesting to explore whether other known regulators of neutrophil 
degranulation, such as Src family kinases, guanosine triphosphatases (GTPases such as Ras 
and Rho) and MAP kinases are also regulated by hypoxia. In addition, hypoxia, PI3K/Akt 
and NF-κB pathways interact to promote pro-inflammatory and HIF-target gene expression. 
Although not explored in the current study, the interplay between hypoxia-mediated 
signalling pathways and NF-κB mediated pathways are likely to be functionally important in 
driving neutrophilic inflammation. [11]  
In summary, the current study by Hoenderdos et al. in this issue of Thorax highlights the 
importance of hypoxia in regulating neutrophil degranulation. The continued release of 
neutrophil-derived proteinases is likely to contribute to the tissue damage observed in acute 
and chronic lung diseases, such as ARDS, CF and COPD. Studying neutrophil function in 
hypoxic conditions ex vivo may therefore reveal novel, drug-targetable cellular and molecular 
processes. The future challenge will be to reproduce the physiological conditions that occur 
within an injured lung as closely as possible. 
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